10. January 2022
Read the Latest News
or Download our Publications.
9. December 2021
Cardea Bio accelerates commercial platform due to demand from market moving partners
To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of...
22. June 2021
Cardea Bio Appoints Experienced Health Technology Executive, Dr. Kelly Huang, as Chief Operating Officer
Expanded Leadership Team Supports Continued Operational and Commercial Growth SAN DIEGO--(BUSINESS...
17. May 2021
Cardea Bio Partners with Scentian Bio to Power Insect Odorant Receptor-Enabled Flavor Profiling Product
SAN DIEGO--(BUSINESS WIRE)--Cardea Bio, a Tech+Bio company integrating molecular biology with...
6. May 2021
The New EV-Chip Biosensor Detects Exosome Cancer & Aging Biomarkers
As the worldwide population ages, a significant challenge will be for healthcare systems to meet...
4. May 2021
Cardea Bio Develops Exosome and Extracellular Vesicles (EV) Detection Technology Called EV-Chip, Showcasing Cancer and Aging Dx Applications
EV-Chip paves way for new generation of portable, point-of-care devices Enables real-time analysis...
4. May 2021
Biotome Partners with Cardea Bio to Develop Graphene-based Precision Immunology Diagnostic Platform
Perth, Australia – May 4, 2021 - Precision diagnostics company Biotome Pty Ltd has entered into a...
30. April 2021